The Daily

Most immune “engager” formats still behave like T-cell missiles: potent, but often brittle in solid tumors. A new Nature Biotechnology paper (s41587-026-03104-5) shifts the focus to macrophages — the cells that actually live in the tumor microenvironment and decide whether antibody-tagged cancer cells get eaten or ignored. The authors describe trispecific immune cell engagers that are designed to both bind tumor targets and re-wire macrophage activity at the same time. The implication is strategic: if you can “turn” macrophages locally, you may need fewer systemic tricks (and potentially fewer toxicities) than classic T-cell recruiting approaches. This is still preclinical, but it’s a clean signal that immunotherapy is broadening beyond T-cells into microenvironment engineering.

Glofitamab (CD20×CD3) looks very different once it leaves trials. In a retrospective real-world cohort of 70 r/r DLBCL patients treated via compassionate use, median prior lines were 4 (and 71% were refractory to their last regimen). Safety was broadly manageable — CRS in 40% (grade 3–4 in 2%), ICANS in 10% (grade 3 in 1%) — but infections were real (31%, grade 5 in 3%). Efficacy: 46% ORR with 27% CR; median PFS 3.6 months, OS 5.7 months. The most actionable detail: recent bendamustine (within 6 months) correlated with significantly reduced PFS — a reminder that T-cell fitness is part of the drug.

A head-to-head preclinical study compares bispecific T-cell engagers (BiTEs) to a DISC1-28z (CD19) “DESCAR-T” strategy for AML, where CAR-T activation and costimulation are assembled via delivered components. In xenograft models, DESCAR-T achieved outcomes comparable to BiTE-based approaches, but with a key mechanistic twist: CD86-driven costimulation (paired with CD33 targeting) looked like a lever to boost depth without widening off-target effects. The reason this matters: if modular CAR logic can be tuned like a dosing regimen, it could make CAR-T behavior more controllable in fast-moving diseases like AML.

This one is painfully mundane and therefore instructive: a deployed source map reportedly exposed the full source for Anthropic’s Claude Code CLI. The story isn’t “AI got hacked”; it’s the same old dev pipeline foot-gun — build artifacts intended for debugging shipping into production. The practical implication is broader than one tool: as AI products ship faster, client-side code + telemetry endpoints become a discovery surface for competitors and attackers alike. If you’re building AI assistants that execute commands, your security model can’t stop at auth — it includes the boring deployment hygiene. This is the kind of leak that doesn’t just reveal code, it reveals workflow.

Slack’s “AI layer” is shifting from add-on to default interface. Salesforce says it’s rolling out 30 new features, including AI tools that summarize conversations, surface context, and help users act on messages without scrolling through threads. The subtext: collaboration apps are racing to become the place where you ask for work — not where you do work. If this lands, Slack becomes less chat log and more command surface for the rest of the enterprise stack. The risk is obvious: once summaries and suggested actions are in the loop, the cost of subtle hallucinations becomes operational.

Wired profiles a patient using a brain implant not just for “signals,” but for expressive control — turning neural activity into music. It’s a reminder that the most compelling near-term BCI applications may be communication and creative output, not sci-fi telepathy. The hard part is reliability: day-to-day stability, calibration drift, and the human learning curve. Still, stories like this show what progress looks like when it’s measured in minutes of usable control, not press-release breakthroughs.

Venice’s most cinematic hotel is doing a real reset. Hospitality Net reports that the Hotel Excelsior Venice Lido will reopen on May 5, 2026 after its most significant transformation in recent history, including a restored Palm Court and redesigned rooms. The headline detail: a new signature terrace restaurant + pool bar + beach club, Amù Venice, with 299 cabanas. This is classic “Venice logistics” packaged as luxury — beach on the Lido, and still ~15 minutes to Piazza San Marco via the hotel’s shuttle boat. For travelers, it’s also a signal: high-end Venice is leaning hard into the Lido as the calm counterweight to the Giardini/San Marco crush.

The Art Newspaper reports that Venice mayor Luigi Brugnaro said the Russian pavilion would be shut down if it engages in propaganda — while insisting the Biennale should remain a forum for “diplomacy and openness.” The controversy follows Russia’s announced return with a musical program, its first appearance since the 2022 full-scale invasion of Ukraine. A hard datapoint inside the story: the Biennale’s Central Pavilion reopened after a 16-month, €31m renovation. If you’re planning Venice around Biennale season, the takeaway is simple: 2026 won’t be a “quiet art year” — it will be intensely contextual.

Hospitality Net details Leonardo Hotels’ strategic expansion in Italy and Poland alongside a debut in Portugal — a small story that points to a bigger travel pattern: major mid-to-upscale chains are accelerating expansion as independent properties struggle with capex and refinancing. For travelers, consolidation usually means more standardized rooms and loyalty perks — but also fewer “weird” boutique surprises. The timing matters too: as demand spreads beyond peak-season cities, chains are chasing secondary markets with year-round occupancy instead of postcard peaks.

Reuters reports Novo Nordisk is leaning into the “patients as consumers” shift with a new discounted subscription plan for U.S. self-pay Wegovy users. The concrete numbers: injection pens at $329/month (3 months), $299 (6 months), and $249 (12 months) versus the usual $349 — a 6% to 29% reduction. It’s being distributed through telehealth partners like Ro, WeightWatchers, and LifeMD, with more expected to join. Strategically, this is Novo defending share against Lilly’s Zepbound pricing ladder and trying to pull patients away from compounded copies. The risk is margin compression turning into an actual price war — but the bigger story is that GLP-1s are now being sold like consumer subscriptions.

After an FDA rejection last September over manufacturing concerns, Biogen has now secured approval for a high-dose regimen of Spinraza (nusinersen) in spinal muscular atrophy. The simplified loading schedule is the key: instead of four induction doses of 12mg, new patients receive two 50mg loading doses 14 days apart, followed by 28mg maintenance injections every four months. BioSpace frames it as a “bridge” move to stabilize a franchise that fell below $1.55B in 2025 (after peaking at $2.097B in 2019). This is what lifecycle management looks like when competition (Evrysdi, gene therapy) is already in the room.

The biotech market doesn’t move on “good science” — it moves on calendar catalysts. BioSpace rounds up six FDA decisions to watch in Q2 2026, a useful lens if you’re tracking volatility rather than mechanism diagrams. The through-line is familiar: label expansions, manufacturing readiness, and whether regulators accept real-world endpoints when trials are messy. It’s also a reminder that in 2026, many of the biggest “binary” moments are no longer for shiny first-in-class assets, but for pragmatic upgrades: dosing, delivery, and post-market evidence.

Kurzliste: Canaletto & Bellotto (KHM) · Courbet (Leopold) · Waldmüller (Unteres Belvedere) · „United by Queerness“ (QWien/ESC) · Donauinsel-Schau (Wien Museum). Im April ist Wien im klassischen Modus: viele Starts, viele Parallelprogramme, und genug Auswahl, um die eigenen Interessen endlich mal ernst zu nehmen (statt nur „eh wieder Albertina“). Praktisch an der wien.info-Liste ist die Breite: von historischer Stadtansicht bis Pop-Kultur (ESC) und Klima-Biennale. Für Planung: einige Highlights haben harte Fenster (z.B. KAWS ab 3.4., Klima Biennale 9.4.–10.5.), andere laufen länger. Mein Tipp: ein fixer „Museumslot“ unter der Woche, dann bleibt das Wochenende frei für Stadt.

Der Standard empfiehlt eine klassische Ferien-Idee, die erstaunlich gut funktioniert: die Ausstellung „World of Bricks“ in der Wiener Stadthalle. Zeitraum: 28. März bis 6. April 2026, Fläche: rund 1.500 Quadratmeter. Es ist genau die Art Event, die sowohl Kinder als auch Erwachsene abholt: große Modelle zum Staunen plus Zonen, wo man selbst wieder ins Basteln kommt. Wenn ihr gehen wollt: lieber vormittags oder unter der Woche — nachmittags wird’s schnell „Familienverkehr“.

Der Standard erzählt die Origin-Story von Maximilian Lambrecht, der es mit einem Fan-Entwurf über „Lego Ideas“ zum offiziellen Set geschafft hat. Das Detail, das hängen bleibt: es ist weniger Strategie als Beharrlichkeit — die Plattform belohnt, was Community und Produkt zusammenbringt. Für Wien ist das eine kleine, aber nette Kultur-Meldung: ein neuer „Maker“-Name, der hier andockt. Und es passt zum April-Vibe: Basteln ist nicht nur Kinderprogramm, sondern ein ernstzunehmender Kreativkanal.

Kurzliste: Lesungen · Illustrations-Workshops · Erzähltheater · Kreativworkshops · Ausstellung mit 1.000+ Kinder- & Jugendbüchern. WIENXTRA kündigt das Kinderliteraturfestival im Theater Odeon (1020) an: von 15. bis 21. April 2026, mit über 50 Programmpunkten und freiem Eintritt. Vormittags ist vieles auf Schulklassen zugeschnitten, nachmittags gibt’s Formate für Ganztagsschulen/Horte. Für Eltern praktisch: Literatur-Events sind wetterunabhängig — und wenn’s draußen weiter „Patchy Rain“ spielt, rettet euch das Wochenprogramm.

Das Technische Museum Wien macht am 24. April 2026 bei der Langen Nacht der Forschung mit — und das ganze Programm ist kostenlos. Fixe Eckdaten: 18:30–22:30, dazu Impulsführungen zur neuen Dauerausstellung „Wissenschaft im Wandel“ alle 30 Minuten (19:00–22:00, ca. 15 Minuten). Für Kinder ab 5 sind Mitmachangebote angekündigt, und das mobile roadLAB bringt Maker-Stuff (3D-Druck, Lasercutter) ins Museum. Das ist genau die Sorte Abend, die Kinder müde macht, ohne dass du dich danach schlecht fühlst.

Wer in den Osterferien einen sicheren Indoor-Plan braucht: das TMW bündelt Workshops für Kinder von 4–12 unter „Technik macht Ferien“, darunter „Materialwelten“ und „Alles, was Flügel hat, fliegt“. Dazu gibt’s Klassiker, die auch kleine Kinder sofort abholen (Modellbahn, „elektrisierte Welt“). Der Vorteil an Museum-Ferienprogrammen: kein „nur anschauen“ — die Kinder bauen, probieren, scheitern und sind am Ende zufrieden kaputt.

Charlotte didn’t just win — they ran Brooklyn off the floor. ESPN’s recap has LaMelo Ball with 29 points as the headline, but the margin tells the story: 117–86 is the kind of scoreline that usually comes with a bench-clearing third quarter. Late-season games can feel like schedule-filler, but blowouts matter because they reveal which teams still have functional habits when legs are gone. For the Hornets, it’s also a reminder that when Ball is healthy, the offense stops looking like improvisation and starts looking like structure.

ESPN reports Victor Wembanyama set the record for the fastest double-double in league history — a neat stat, but it’s also a reminder of the scale: he’s putting “center numbers” up in guard time. Records like this are partly pace, partly usage, but mostly talent density. For San Antonio, the win/loss reality is still messy — yet the developmental signal is unmistakable: the floor for Wemby games is now “historic footnote.”

NBA.com’s nightly highlight package is the cleanest way to see how the numbers happened: spacing, contests, and the weird geometry Wembanyama creates around the rim. It’s also the best antidote to stat inflation — you can tell within 30 seconds if a “monster line” was garbage time or real leverage. This one looks like leverage.